Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. It operates in two segments, Engineering and Other Scientific; and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, engineering management consulting, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, statistical and data sciences, technology development, thermal sciences, and vehicle analysis. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, occupational and environmental health risk assessment, and toxicology and mechanistic biology, as well as epidemiology, biostatistics, and computational biology. The company offers approximately 90 different technical disciplines to solve complicated issues facing industry and government. It serves clients in automotive, aviation, chemical, construction, consumer products, energy, government, health, insurance, manufacturing, technology, and other sectors. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. Exponent, Inc. was founded in 1967 and is headquartered in Menlo Park, California.
Exponent beats 3Q profit forecasts MENLO PARK, Calif. (AP) _ Exponent Inc. (EXPO) on Wednesday reported third-quarter earnings of $11.3 million. On a per-share basis, the Menlo Park, California-based company said it had net income of 42 cents. The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 33 cents per share. The engineering and scientific consulting company posted revenue of $74.2 million in the period. Exponent shares have risen slightly since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $50.12, an increase of roughly 3 percent in the last 12 months.
